
A fund that invests in international companies that went public in the past few years is beating its U.S. counterpart. Japan’s Kioxia is a big reason why.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

A fund that invests in international companies that went public in the past few years is beating its U.S. counterpart. Japan’s Kioxia is a big reason why.
This AI chipmaker and cloud services provider has a bright future.
Both offer exposure to the AI infrastructure build-out, but investors need to understand the very different risks behind each stock.
SpaceX’s shares are set to begin trading on the Nasdaq on Friday, with the company having raised $75 billion at a valuation of $1.77 trillion.
It's important to consider your comfort with risk before diving in.
These companies are both promising players in the AI space.
The early momentum for Cerebras fizzled out quickly after it went public.
It's key to consider your risk tolerance before making any decisions.
Cerebras offers a bold alternative to traditional AI chips, but CBRS stock’s explosive debut raises valuation concerns.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.